Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-046887)

Filing Details

Accession Number:: 0000899243-21-046887
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-06 08:11:27
Reporting Period:: 2021-12-02

Accepted Time:: 2021-12-06 08:11:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840574	Verve Therapeutics Inc.	VERV	()	MA

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1226283	A Burt Adelman	C/O Verve Therapeutics, Inc. 500 Technology Square, Suite 901 Cambridge MA 02139		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-02	4,700	$31.34	4,700	No	4	P	Indirect	Burt A Adelman 2002 Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Burt A Adelman 2002 Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	409,626	Indirect	The Burt A. Adelman 2021 GRAT

Footnotes

Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $31.13 to $31.37 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.